Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: A randomised factorial controlled equivalence trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 3, 2009, Pages 381-389

  Von Hertzen, H ^a   Piaggio, G ^b   Wojdyla, D ^b   Marions, L ^b   My Huong, N T ^b   Tang, O S ^b   Fang, A H ^b   Wu, S C ^b   Kalmar, L ^b   Mittal, S ^b   Erdenetungalag, R ^b   Horga, M ^b   Pretnar Darovec, A ^b   Kapamadzija, A ^b   Dickson, K ^b   Anh, N D ^b   Tai, N V ^b   Tuyet, H T D ^b   Peregoudov, A ^b  

^a WORLD BANK   (United States)

^b NONE

Author keywords

Medical abortion; Mifepristone dose; Mifepristone misoprostol interval

Indexed keywords

ANTIBIOTIC AGENT; MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FEVER; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEADACHE; HUMAN; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; MEDICAL ABORTION; NAUSEA; OUTCOME ASSESSMENT; PREGNANCY TERMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHIVERING; VAGINITIS; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TABLETS; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 58549097487     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.02034.x     Document Type: Article

References (19)

1. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993 307 : 532 7.
2. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Comparison of two doses of mifepristone in combination of misoprostol for early medical abortion: a randomized trial. BJOG 2000 107 : 524 30.
3. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost: a randomized controlled trial. Acta Obstet Gynecol Scand 2001 80 : 447 51.
4. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Pregnancy termination with mifepristone and gemeprost: a multicentre comparison between repeated doses and a single dose of mifepristone. Fertil Steril 1991 56 : 32 40.
5. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Lowering the doses of mifepristone and gemeprost for early abortion: a randomised controlled trial. BJOG 2001 108 : 738 42.
6. Heikinheimo O, Kekkonen R. Dose-response relationship of RU 486. Ann Med 1993 25 : 71 6.
7. Bygdeman M, Swahn ML. Progesterone receptor blockage-effect on uterine contractility and early pregnancy. Contraception 1985 32 : 45 51.
8. Ashok PW, Flett GM, Templeton A. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol 2000 183 : 998 1002.
9. Ulmann A, Silvestre L, Chemama L, Rezvani Y, Renault M, Aguillaume CJ, et al. Medical termination of early pregnancy with mifepristone (RU486) followed by a prostaglandin analogue. Study in 16,369 women. Acta Obstet Gynecol Scand 1992 71 : 278 83.
10. Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 2000 284 : 1948 53.
11. Creinin MD, Schreiber CA, Bednarek P, Lintu H, Wagner M-S, Meyn LA for the MAST Study Trial Group. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion. Obstet Gynecol 2007 109 : 885 94.
12. Guest J, Chien PF, Thomson MA, Kosseim ML. Randomized controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36-48 hour protocol. BJOG 2007 114 : 207 15.
13. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extention of the CONSORT statement. JAMA 2006 295 : 1152 60.
14. Creinin MC, Pymar HC, Schwartz JL. Mifepristone 100 mg in abortion regimens. Obstet Gynecol 2001 98 : 434 9.
15. Aronsson A, Bygdeman M, Gemzell-Danielsson K. Effects of mifepristone on uterine contractility following different routes of administration. Hum Reprod 2004 19 : 81 4.
16. Heikinheimo O, Suhonen S, Haukkamaa M. One-and two-day mifepristone-misoprostol intervals are both effective in medical termination of second trimester pregnancy. Reprod Biomed Online 2004 8 : 236 9.
17. von Hertzen H, Piaggio G, Huong NT, Arustamyan K, Cabezas E, Gomez M, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomized controlled equivalence trial. Lancet 2007 369 : 1938 46.
18. von Hertzen H, Honkanen H, Piaggio G, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion: I Efficacy. BJOG 2003 110 : 808 18.
19. Suhonen S, Heikinheimo O, Tikka M, Haukkamaa M. The learning curve is rapid in medical termination of pregnancy-first year results from the Helsinki area. Contraception 2003 67 : 223 7.